- Home
- EDSA vs CXAI Comparison
EDSA vs CXAI Comparison
Compare EDSA & CXAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EDSA
- CXAI
- Stock Information
- Founded
- EDSA 2015
- CXAI N/A
- Country
- EDSA Canada
- CXAI United States
- Employees
- EDSA N/A
- CXAI N/A
- Industry
- EDSA Biotechnology: Pharmaceutical Preparations
- CXAI EDP Services
- Sector
- EDSA Health Care
- CXAI Technology
- Exchange
- EDSA Nasdaq
- CXAI Nasdaq
- Market Cap
- EDSA 17.5M
- CXAI 17.8M
- IPO Year
- EDSA N/A
- CXAI N/A
- Fundamental
- Price
- EDSA $2.72
- CXAI $0.93
- Analyst Decision
- EDSA Strong Buy
- CXAI
- Analyst Count
- EDSA 2
- CXAI 0
- Target Price
- EDSA $13.00
- CXAI N/A
- AVG Volume (30 Days)
- EDSA 121.9K
- CXAI 767.9K
- Earning Date
- EDSA 08-08-2025
- CXAI 11-11-2025
- Dividend Yield
- EDSA N/A
- CXAI N/A
- EPS Growth
- EDSA N/A
- CXAI N/A
- EPS
- EDSA N/A
- CXAI N/A
- Revenue
- EDSA N/A
- CXAI $6,005,000.00
- Revenue This Year
- EDSA N/A
- CXAI N/A
- Revenue Next Year
- EDSA N/A
- CXAI $60.00
- P/E Ratio
- EDSA N/A
- CXAI N/A
- Revenue Growth
- EDSA N/A
- CXAI N/A
- 52 Week Low
- EDSA $1.55
- CXAI $0.61
- 52 Week High
- EDSA $4.49
- CXAI $2.54
- Technical
- Relative Strength Index (RSI)
- EDSA 62.87
- CXAI 63.61
- Support Level
- EDSA $2.47
- CXAI $0.79
- Resistance Level
- EDSA $2.82
- CXAI $0.88
- Average True Range (ATR)
- EDSA 0.18
- CXAI 0.05
- MACD
- EDSA 0.03
- CXAI 0.02
- Stochastic Oscillator
- EDSA 85.46
- CXAI 94.89
About EDSA Edesa Biotech Inc.
Edesa Biotech Inc is a biotechnology company focused on inflammatory and immune-related diseases. It is involved in exploring novel ways to treat these diseases, including alternatives to topical steroids, which can have side effects. The company's product candidate, EB06, is an anti-CXCL10 monoclonal antibody candidate and is being developed as a therapy for vitiligo, a common autoimmune disorder that causes the skin to lose its color in patches. The other drug candidates in its product pipeline include EB05, EB07, and EB01 which are in their different phases of development.
About CXAI CXApp Inc.
CXApp Inc is a provider of AI-powered employee experience solutions, delivering enterprise-grade software that enhances workplace engagement, productivity, and operational efficiency. The company's flagship product, the CXAI Platform, provides a comprehensive suite of tools designed to empower employees and enable organizations to create smarter workplaces. The product's key components include CXAI Apps, CXAI BTS, and CXAI-VU. The company generates the majority of its revenue from Licenses.